Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nyxol for Reversal of Pharmacologically Induced Mydriasis
NCT04024891Phase 2Completed
- Sponsor
- Opus Genetics
- Start
- Aug 2019
- Primary completion
- Sep 2019
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of phentolamine in Mydriasis, sponsored by Opus Genetics. Started Aug 2019; status: completed.
02
Drugs
phentolamine
03
Conditions
Mydriasis
Beyond the preview
Go deeper on NCT04024891.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04024891.